# HISTO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/histo

- Industry: Healthcare Specialists
- Headquarters: Shanghai, China
- Website: www.histo.cn
- Latest round: Series B (May 28, 2024)
- Investors on record: 5

## About

Established in 2011 and based in Shanghai, China, HistoMed is an institution in the field of pathology diagnostics. The company has expanded its operations with branches and centers in various locations, including a pathology center in Beijing, and also has a 5,700 square meter laboratory. The company also provides genome chips platform with more than 20 intelligent reports about molecular pathology of cancer species. Besides, the company has media platform for expertise communication. In May 2024, it closed a round of series B+ funding.

The company offers a wide range of pathology services, including digital remote diagnostics, frozen biopsy, histological pathology diagnosis, cytological pathology diagnosis, immunohistochemistry and special staining, molecular pathology differential diagnosis, and companion diagnostics for various precision treatments. The company's services are geared towards providing solutions for routine pathology diagnostics, expert consultations, and pharmaceutical standardization services, enabling nationwide sharing of diagnostic resources.

The company generates revenue by providing pathology diagnostic services, digital pathology solutions, and collaborating with pharmaceutical companies and healthcare institutions for standardized services and clinical trials.

The company will use the series B+ funding raised in May 2024 to further enhance its digital pathology capabilities and meet the evolving demands of the medical market.

## Funding rounds

- Series B, May 28, 2024 — Puhua Capital, Zhejiang Changxing Financial Holding Group
- Series A, Jan 15, 2019 — WI Harper Group, SenseTime Group Limited, Tendence Capital

## Investors

- WI Harper Group (https://capitalatlas.ai/funds/wi-harper-group) — Series A
- SenseTime Group Limited — Series A
- Tendence Capital (https://capitalatlas.ai/funds/tendence-capital) — Series A
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Series B
- Zhejiang Changxing Financial Holding Group — Series B